Anti-viral effects of urosolic acid on guinea pig cytomegalovirus in vitro

Abstract

This study examined the anti-viral effect of ursolic acid on guinea pig cytomegalovirus (GPCMV) and explored the steps of viral replication targeted by ursolic acid. Cytopathic effect assay and MTT method were employed to determine the 50% cellular cytotoxicity (CC₅₀), 50% effective concentration (EC₅₀) and therapeutic index (TI) with GPCMV. To investigate the specific anti-viral effect of ursolic acid at different temperatures and time points, two other medicines, ganciclovir and Jinyebaidu (JYBD), serving as controls, were studied for comparison. Our results showed that the CC50 of ganciclovir, JYBD and ursolic acid were 333.8, 3015.6, 86.7 μg/mL, respectively; EC₅₀ of ganciclovir, JYBD and ursolic acid was 48.1, 325.5 and 6.8 μg/mL, respectively; TI of ganciclovir, JYBD and ursolic acid was 7, 9, 13, respectively. Similar with ganciclovir, ursolic acid could inhibit the viral synthesis, but did not affect the viral adsorption onto and penetration into cells. We are led to conclude that the anti-cytomegalovirus effect of ursolic acid is significantly stronger than ganciclovir or JYBD, and the cytotoxic effect of ursolic acid lies in its ability to inhibit viral synthesis.

References

[1] KoyanoS., InoueN., NagamoriT., et al.. Dried umbilicalcords in the retrospective diagnosis of congenital cytomegalovirus infection as a cause of developmental delays. Clin Infec Dis, 2009, 48(10): 93-95

[2] OgawaH., SuzutaniT.. Etiology of severe sensorineural hearing loss in children: independent impact of congenital cytomegalovirus infection and GJB2 mutations. J Infect Dis, 2007, 195(6): 782-788

[3] TsutsuiY.. Effects of cytomegalovirus infection on embryogenesis and brain development. Congenit Anom (Kyoto), 2009, 49(2): 47-55

[4] ChenS., XiongJ., XingW., et al.. A study on the traditional Chinese medicine Jinyebaidu for prevention and treatment of intrauterine infection with guinea pigs cytomegalovirus. J Huazhong Univ Sci Technol [Med Sci], 2005, 25(6): 721-723

[5] KashiwadaY., NagaoT., HashimotoA.. Anti-AIDS agents 38. Anti-HIV activity of 3-O-acyl ursolic acid derivatives. J Nat Prod, 2000, 63(12): 1619-1622

[6] QuéréL., WengerT., SchrammH.J.. Triterpenes as potential dimerization inhibitors of HIV-1 protease. Biochem Biophys Res Commun, 1996, 227(2): 484-488

[7] ChiangL.C., NgL.T., ChengP.W., et al.. Antiviral activities of extracts and selected pure constituents of Ocimum basilicum. Clin Exp Pharmacol Physiol, 2005, 32(10): 811-816

[8] MutoY., NinomiyaM., FujikiH.. Present status of research on cancer chemoprevention in Japan. Jpn J Clin Oncol, 1990, 20(3): 219-224

[9] QiaoY., MengL., WangJ., et al.. Effect of ganciclovir on murine cytomegalovirus-induced hearing loss in a mouse model. Cell Biochem Biophys, 2011, 61(2): 407-412

[10] HayashiK., MinodaK., NagaokaY., et al.. Antiviral activity of berberine and related compounds against human cytomegalovirus. Bioorg Med Chem Lett, 2007, 17(6): 1562-1564

[11] ZhouY.. LD50 with SPSS software calculation of new drugs. Progress in Pharmaceutical Science, 2003, 27(5): 314-316

[12] BrittW.J., VuglerL.G.. Antiviral antibody responses in mothers and their newborn infants with clinical and sub clinical congenital cytomegalovirus infections. J Infect Dis, 1990, 161(2): 214-219

[13] KanoY., ShioharaT.. Current understanding of cytomegalovirus infection in immunocompetent individuals. J Dermatol Sci, 2000, 22(3): 196-204

[14] LiX.D., JinH.. The research progess of congenital cytomegalovirus infection teratogenic mechanism. Section Virology Foreign Med Sci, 2004, 11(4): 128-130

[15] DaiD.Y.Practical drug apt manual, 1997, Beijing, People’s Medical Publishing House(Chinese)

[16] YangH.X.Pregnancy and lactation drug use, 2008, Beijing, People’s Medical Publishing House: 542-544

[17] JiangX.J.. Congenital cytomegalovirus infection status. Military Med J South China (Chinese), 2009, 23(3): 91-93

[18] SchleissM.R.. Cytomegalovirus vaccine development. Curr Top Microbiol Immunol, 2008, 32(5): 361-382

[19] KimD.K., BaekJ.H., KangC.M., et al.. Apoptotic activity of ursolic acid may correlate with the inhibition of initiation of DNA replication. Int J Cancer, 2000, 87(5): 629-636

[20] SlamenováD., HorváthováE., BartkováM., et al.. Reduction of DNA-damaging effects of anti-HIV drug 3′-azido-3′-dideoxythymidine on human cells by ursolic acid and lignin biopolymer. Neoplasma, 2006, 53(6): 485-491

[21] IkedaY., MurakamiA., OhigashiH.. Ursolic acid: an anti- and pro-inflammatory triterpenoid. Mol Nutr Food Res, 2008, 52(1): 26-42

RIGHTS & PERMISSIONS

Huazhong University of Science and Technology and Springer-Verlag Berlin Heidelberg